Correlation Between Utah Medical and BioLife Sciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Utah Medical and BioLife Sciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Utah Medical and BioLife Sciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Utah Medical Products and BioLife Sciences, you can compare the effects of market volatilities on Utah Medical and BioLife Sciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Utah Medical with a short position of BioLife Sciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Utah Medical and BioLife Sciences.

Diversification Opportunities for Utah Medical and BioLife Sciences

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Utah and BioLife is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Utah Medical Products and BioLife Sciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BioLife Sciences and Utah Medical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Utah Medical Products are associated (or correlated) with BioLife Sciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BioLife Sciences has no effect on the direction of Utah Medical i.e., Utah Medical and BioLife Sciences go up and down completely randomly.

Pair Corralation between Utah Medical and BioLife Sciences

Given the investment horizon of 90 days Utah Medical Products is expected to under-perform the BioLife Sciences. But the stock apears to be less risky and, when comparing its historical volatility, Utah Medical Products is 62.88 times less risky than BioLife Sciences. The stock trades about -0.04 of its potential returns per unit of risk. The BioLife Sciences is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest  0.20  in BioLife Sciences on November 2, 2024 and sell it today you would lose (0.19) from holding BioLife Sciences or give up 95.0% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy99.8%
ValuesDaily Returns

Utah Medical Products  vs.  BioLife Sciences

 Performance 
       Timeline  
Utah Medical Products 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Utah Medical Products has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound primary indicators, Utah Medical is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.
BioLife Sciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days BioLife Sciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical and fundamental indicators, BioLife Sciences is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.

Utah Medical and BioLife Sciences Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Utah Medical and BioLife Sciences

The main advantage of trading using opposite Utah Medical and BioLife Sciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Utah Medical position performs unexpectedly, BioLife Sciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioLife Sciences will offset losses from the drop in BioLife Sciences' long position.
The idea behind Utah Medical Products and BioLife Sciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.

Other Complementary Tools

ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities